Cell surface Nestin is a biomarker for glioma stem cells

Xiong Jin, Xun Jin, Ji Eun Jung, Samuel Beck, Hyunggee Kim

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Cancer stem cells (CSCs) are the most aggressive cell type in many malignancies. Cell surface proteins are generally used to isolate and characterize CSCs. Therefore, the identification of CSC-specific cell surface markers is very important for the diagnosis and treatment of malignancies. We found that Nestin (a type VI intermediate filament protein), like the glioma stem cell (GSC) markers CD133 and CD15, exhibited different levels of expression in primary human glioblastoma specimens. Similar to our previous finding that cytoplasmic Nestin is expressed as a cell surface form in mouse GSCs, the cell surface form of Nestin was also expressed at different levels in human GSCs. We isolated cell surface Nestin-positive cell populations from human GSCs by fluorescence-activated cell sorting FACS analysis, and observed that these populations exhibited robust CSC properties, such as increased tumorsphere-forming ability and tumorsphere size. Mechanistically, we found that DAPT, a γ-secretase (a multi-subunit protease complex) inhibitor, reduced the proportion of cell surface Nestin-positive cells in human GSCs in a time- and dose-dependent manner, without significant changes in total Nestin expression, implying that a post-translational modification was involved in the generation of cell surface Nestin. Taken together, our data provides the first evidence that cell surface Nestin may serve as a promising GSC marker for the isolation and characterization of heterogeneous GSCs in glioblastomas.

Original languageEnglish
Pages (from-to)496-501
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume433
Issue number4
DOIs
Publication statusPublished - 2013 Apr 19

Fingerprint

Nestin
Biomarkers
Stem cells
Glioma
Stem Cells
Neoplastic Stem Cells
Cells
Glioblastoma
Intermediate Filament Proteins
Amyloid Precursor Protein Secretases
Sorting
Cell Separation
Post Translational Protein Processing
Membrane Proteins
Protease Inhibitors
Peptide Hydrolases
Fluorescence
Population
Neoplasms
Flow Cytometry

Keywords

  • γ-Secretase
  • Glioblastoma
  • Glioma stem cells
  • Nestin

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Cell surface Nestin is a biomarker for glioma stem cells. / Jin, Xiong; Jin, Xun; Jung, Ji Eun; Beck, Samuel; Kim, Hyunggee.

In: Biochemical and Biophysical Research Communications, Vol. 433, No. 4, 19.04.2013, p. 496-501.

Research output: Contribution to journalArticle

Jin, Xiong ; Jin, Xun ; Jung, Ji Eun ; Beck, Samuel ; Kim, Hyunggee. / Cell surface Nestin is a biomarker for glioma stem cells. In: Biochemical and Biophysical Research Communications. 2013 ; Vol. 433, No. 4. pp. 496-501.
@article{03060265ddb74e938c7bb023696fb272,
title = "Cell surface Nestin is a biomarker for glioma stem cells",
abstract = "Cancer stem cells (CSCs) are the most aggressive cell type in many malignancies. Cell surface proteins are generally used to isolate and characterize CSCs. Therefore, the identification of CSC-specific cell surface markers is very important for the diagnosis and treatment of malignancies. We found that Nestin (a type VI intermediate filament protein), like the glioma stem cell (GSC) markers CD133 and CD15, exhibited different levels of expression in primary human glioblastoma specimens. Similar to our previous finding that cytoplasmic Nestin is expressed as a cell surface form in mouse GSCs, the cell surface form of Nestin was also expressed at different levels in human GSCs. We isolated cell surface Nestin-positive cell populations from human GSCs by fluorescence-activated cell sorting FACS analysis, and observed that these populations exhibited robust CSC properties, such as increased tumorsphere-forming ability and tumorsphere size. Mechanistically, we found that DAPT, a γ-secretase (a multi-subunit protease complex) inhibitor, reduced the proportion of cell surface Nestin-positive cells in human GSCs in a time- and dose-dependent manner, without significant changes in total Nestin expression, implying that a post-translational modification was involved in the generation of cell surface Nestin. Taken together, our data provides the first evidence that cell surface Nestin may serve as a promising GSC marker for the isolation and characterization of heterogeneous GSCs in glioblastomas.",
keywords = "γ-Secretase, Glioblastoma, Glioma stem cells, Nestin",
author = "Xiong Jin and Xun Jin and Jung, {Ji Eun} and Samuel Beck and Hyunggee Kim",
year = "2013",
month = "4",
day = "19",
doi = "10.1016/j.bbrc.2013.03.021",
language = "English",
volume = "433",
pages = "496--501",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "4",

}

TY - JOUR

T1 - Cell surface Nestin is a biomarker for glioma stem cells

AU - Jin, Xiong

AU - Jin, Xun

AU - Jung, Ji Eun

AU - Beck, Samuel

AU - Kim, Hyunggee

PY - 2013/4/19

Y1 - 2013/4/19

N2 - Cancer stem cells (CSCs) are the most aggressive cell type in many malignancies. Cell surface proteins are generally used to isolate and characterize CSCs. Therefore, the identification of CSC-specific cell surface markers is very important for the diagnosis and treatment of malignancies. We found that Nestin (a type VI intermediate filament protein), like the glioma stem cell (GSC) markers CD133 and CD15, exhibited different levels of expression in primary human glioblastoma specimens. Similar to our previous finding that cytoplasmic Nestin is expressed as a cell surface form in mouse GSCs, the cell surface form of Nestin was also expressed at different levels in human GSCs. We isolated cell surface Nestin-positive cell populations from human GSCs by fluorescence-activated cell sorting FACS analysis, and observed that these populations exhibited robust CSC properties, such as increased tumorsphere-forming ability and tumorsphere size. Mechanistically, we found that DAPT, a γ-secretase (a multi-subunit protease complex) inhibitor, reduced the proportion of cell surface Nestin-positive cells in human GSCs in a time- and dose-dependent manner, without significant changes in total Nestin expression, implying that a post-translational modification was involved in the generation of cell surface Nestin. Taken together, our data provides the first evidence that cell surface Nestin may serve as a promising GSC marker for the isolation and characterization of heterogeneous GSCs in glioblastomas.

AB - Cancer stem cells (CSCs) are the most aggressive cell type in many malignancies. Cell surface proteins are generally used to isolate and characterize CSCs. Therefore, the identification of CSC-specific cell surface markers is very important for the diagnosis and treatment of malignancies. We found that Nestin (a type VI intermediate filament protein), like the glioma stem cell (GSC) markers CD133 and CD15, exhibited different levels of expression in primary human glioblastoma specimens. Similar to our previous finding that cytoplasmic Nestin is expressed as a cell surface form in mouse GSCs, the cell surface form of Nestin was also expressed at different levels in human GSCs. We isolated cell surface Nestin-positive cell populations from human GSCs by fluorescence-activated cell sorting FACS analysis, and observed that these populations exhibited robust CSC properties, such as increased tumorsphere-forming ability and tumorsphere size. Mechanistically, we found that DAPT, a γ-secretase (a multi-subunit protease complex) inhibitor, reduced the proportion of cell surface Nestin-positive cells in human GSCs in a time- and dose-dependent manner, without significant changes in total Nestin expression, implying that a post-translational modification was involved in the generation of cell surface Nestin. Taken together, our data provides the first evidence that cell surface Nestin may serve as a promising GSC marker for the isolation and characterization of heterogeneous GSCs in glioblastomas.

KW - γ-Secretase

KW - Glioblastoma

KW - Glioma stem cells

KW - Nestin

UR - http://www.scopus.com/inward/record.url?scp=84876472575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876472575&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2013.03.021

DO - 10.1016/j.bbrc.2013.03.021

M3 - Article

VL - 433

SP - 496

EP - 501

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 4

ER -